ARTICLE | Financial News

RXi amends follow-on

November 15, 2016 9:25 PM UTC

RXi amended its follow-on and now plans to sell 2 million class A units and 9,600 class B units. The company also added Griffin Securities as an underwriter; Ladenburg Thalmann is also an underwriter....

BCIQ Company Profiles

Phio Pharmaceuticals Corp.